About Patient IP
Patient IP is a company based in Rochester (United States) founded in 2014.. Patient IP has raised $2.2 million across 2 funding rounds. Patient IP operates in a competitive market with competitors including Elligo, Acurian, Velocity Clinical Research, CenExel and Wake Research, among others.
- Headquarter Rochester, United States
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.2 M (USD)
in 2 rounds
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Patient IP
Patient IP has successfully raised a total of $2.2M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(24 Sep 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2015 | Amount | Series A - Patient IP | Valuation |
investors |
|
| Sep, 2015 | Amount | Debt – Conventional - Patient IP | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Patient IP
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Patient IP
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Patient Ip Comparisons
Competitors of Patient IP
Patient IP operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Elligo, Acurian, Velocity Clinical Research, CenExel and Wake Research, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Patient recruitment and site activation services are provided by Elligo.
|
|
| domain | founded_year | HQ Location |
Patient enrollment and retention solutions for clinical trials are offered.
|
|
| domain | founded_year | HQ Location |
Provider of site management and patient recruitment services
|
|
| domain | founded_year | HQ Location |
Research site management and patient recruitment services are provided.
|
|
| domain | founded_year | HQ Location |
Clinical site management, patient recruitment, and retention services are provided.
|
|
| domain | founded_year | HQ Location |
Clinical trial recruitment service company
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Patient Ip
Frequently Asked Questions about Patient IP
When was Patient IP founded?
Patient IP was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Patient IP located?
Patient IP is headquartered in Rochester, United States.
Is Patient IP a funded company?
Patient IP is a funded company, having raised a total of $2.2M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.2M, raised on Sep 24, 2015.
What does Patient IP do?
Patient IP, established in 2014 and currently in Dissolved stage, focuses on it serves as a patient ip leverages existing ehr data to improve site selection and match ideal patients to clinical trial criteria. It serves as a patient ip leverages existing ehr data to improve site selection and match ideal patients to clinical trial criteria. Adapting to market demands with innovation.
Who are the top competitors of Patient IP?
Patient IP's top competitors include Velocity Clinical Research, Elligo and Acurian.